An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol

This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.

Inclusion Criteria:

• Adult patients, >/= 18 years of age
• Recipients of renal allograft
• Patients receiving CellCept

Exclusion Criteria:

• N/A